发明名称 PHARMACEUTICAL COMPOSITIONS
摘要 "The invention concerns a pharmaceutical composition comprising the HMG CoA reductase inhibitor (E)-7-¢4-(4-fluorophenyl)-6-isopropyl-2-¢methyl(methylsulfonyl)amino!pyrimidin-5-yl!-(3R,SS)-3,5-dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof as the active ingredient, which remains stable over a prolonged period."
申请公布号 CA2313783(A1) 申请公布日期 2000.10.16
申请号 CA20002313783 申请日期 2000.08.04
申请人 ASTRAZENECA AB 发明人 WIGGINS, NORMAN ALFRED;CREEKMORE, JOSEPH RICHARD
分类号 C07D239/42;A61K9/14;A61K9/20;A61K9/22;A61K31/505;A61K47/02;A61K47/04;A61K47/14;A61K47/26;A61K47/38;A61P3/00;A61P3/06;A61P9/10;A61P19/00;A61P43/00;(IPC1-7):A61K31/505 主分类号 C07D239/42
代理机构 代理人
主权项
地址